- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kyowa Kirin Co Ltd (4151)
Kyowa Kirin Co Ltd stock price live, this page displays TYO 4151 stock exchange data. View the 4151 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kyowa Kirin Co Ltd real time stock price chart below.
What Is the Kyowa Kirin Co Ltd Stock Price Today?
The Kyowa Kirin Co Ltd stock price today is 2,300.0.
What Is the Stock Symbol for Kyowa Kirin Co Ltd?
The stock symbol for Kyowa Kirin Co Ltd is ""4151.""
What Stock Exchange Does Kyowa Kirin Co Ltd Trade On?
Kyowa Kirin Co Ltd is listed and trades on the Tokyo stock exchange.
Is Kyowa Kirin Co Ltd a Good Stock to Buy?
Determining whether Kyowa Kirin Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4151 quote. (ISIN: JP3256000005)
What Is the Kyowa Kirin Co Ltd Stock Price Today?
The Kyowa Kirin Co Ltd stock price today is 2,300.0.
What Is the Stock Symbol for Kyowa Kirin Co Ltd?
The stock symbol for Kyowa Kirin Co Ltd is ""4151.""
What Stock Exchange Does Kyowa Kirin Co Ltd Trade On?
Kyowa Kirin Co Ltd is listed and trades on the Tokyo stock exchange.
Is Kyowa Kirin Co Ltd a Good Stock to Buy?
Determining whether Kyowa Kirin Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4151 quote. (ISIN: JP3256000005)
2,300.0
-19.0(-0.82%)
Closed·
Fair Value
An estimate of a Kyowa Kirin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,265.5
2,301.5
52 wk Range
2,025.0
2,706.0
4151 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4151 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Kyowa Kirin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,265.52,301.5
52 wk Range
2,025.02,706.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4151 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kyowa Kirin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
2,572.7
Upside
+11.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 9 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Kyowa Kirin Co Ltd Company Profile
Kyowa Kirin Co., Ltd. engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide. The company offers Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; POTELIGEO for the treatment of cutaneous T-cell lymphoma; Nouriast/Nourianz, an adenosine A2A receptor antagonist; G-LASTA, a mobilization of hematopoietic stem cells into peripheral blood for autologous blood stem cell transplantation; Libmeldy/Lenmeldy for treating metachromatic leukodystrophy; Orkedia for treatment of secondary hyperparathyroidism; and Romiplate to treat aplastic anemia. It also develops OTL-203 for the treatment of mucopolysaccharidosis type IH (hurler syndrome); KHK4083/AMG 451 to treat atopic dermatitis, prurigo nodularis, and asthma; OTL-201 for the treatment of mucopolysaccharidosis type IIIA (sanfilippo syndrome type A); ziftomenib for treating R/R acute myeloid Leukemia and acute lymphoblastic leukemia; KHK4951 for the treatment of diabetic macular edema and neovascular age-related macular degeneration; KK8123 to treat x-linked hypophosphatemia; KK2845 for the treatment of acute myeloid leukemia; KK4277 for treating systemic and cutaneous lupus erythematosus; Lumicef to treat palmoplantar pustulosis; KK2260 and KK2269 for the treatment of solid tumors; and KK8398 for the treatment of achondroplasia. The company was formerly known as Kyowa Hakko Kirin Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in June 2019. The company was incorporated in 1949 and is headquartered in Tokyo, Japan. Kyowa Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.
Compare 4151 to Peers and Sector
Metrics to compare | 4151 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4151PeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.6x | 15.3x | −0.7x | |
PEG Ratio | −0.53 | 0.11 | 0.00 | |
Price/Book | 1.4x | 1.1x | 2.6x | |
Price / LTM Sales | 2.5x | 1.5x | 3.4x | |
Upside (Analyst Target) | 7.8% | 5.6% | 37.8% | |
Fair Value Upside | Unlock | 13.9% | 5.5% | Unlock |
Analyst Ratings
5 Buy
6 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,572.7
(+11.86% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
19.40 / 31.83
Revenue / Forecast
125.93B / 120.95B
People Also Watch
FAQ
What Stock Exchange Does Kyowa Kirin Trade On?
Kyowa Kirin is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Kyowa Kirin?
The stock symbol for Kyowa Kirin is "4151."
What Is the Kyowa Kirin Market Cap?
As of today, Kyowa Kirin market cap is 1.20T.
What Is Kyowa Kirin's Earnings Per Share (TTM)?
The Kyowa Kirin EPS (TTM) is 73.27.
When Is the Next Kyowa Kirin Earnings Date?
Kyowa Kirin will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is 4151 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kyowa Kirin Stock Split?
Kyowa Kirin has split 0 times.
How Many Employees Does Kyowa Kirin Have?
Kyowa Kirin has 5669 employees.
What is the current trading status of Kyowa Kirin (4151)?
As of 14 Oct 2025, Kyowa Kirin (4151) is trading at a price of 2,300.0, with a previous close of 2,319.00. The stock has fluctuated within a day range of 2,265.5 to 2,301.5, while its 52-week range spans from 2,025.0 to 2,706.0.
What Is Kyowa Kirin (4151) Price Target According to Analysts?
The average 12-month price target for Kyowa Kirin is JPY2572.72727, with a high estimate of JPY3000 and a low estimate of JPY2000. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +11.86% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.